Despite the promise of OCTA as a valuable tool in the evaluation of diabetic retinopathy and its complications, challenges remain and more research is needed to standardize its use in clinical ...

I was recently diagnosed with Type 2 diabetes. My health care professional shared that I’ll need to have regular eye exams in ...

Hypertensive retinopathy results from high blood pressure, while diabetic retinopathy is a diabetes complication. Share on Pinterest 1584740802 Hiraman/Getty Images Your retinas are part of your ...

Diabetic retinopathy (DR) is an eye-related complication that can occur in people who have diabetes. It affects blood vessels in the retina - the "light-sensitive layer of tissue in the back of ...

Diabetic retinopathy can lead to peripheral or nighttime vision loss, visual disturbances, and, if left untreated, blindness. advertisement.

Diabetic patients with high myopia have a significantly lower choroidal vascularity index (CVI) than those with diabetic retinopathy (DR), according to research published in Frontiers in Cell and ...

If it’s left untreated, diabetic retinopathy can lead to serious, sight-stealing complications. Here’s what to know.

What are IRMAs and how do they develop with diabetic retinopathy? Read on to learn more about this potential eye complication, ... (OCTA), to help distinguish between IRMAs and neovascularization.

If you have diabetes, you may get a condition called diabetic retinopathy. It’s the most common cause of vision loss among people with diabetes. WebMD explains the stages of this disease and how ...

A sensitivity analysis of those who had type 2 diabetes for at least 5 years showed that cataract surgery was tied to increased 1-year risks of PDR without complications (HR 1.52, 95% CI 1.06-2.19 ...

Non-proliferative diabetic retinopathy, or NPDR, is a form of diabetic retinopathy. NDPR occurs when diabetes damages small blood vessels within the retina. These vessels start to leak both fluid and ...

Vision-threatening complications, such as proliferative diabetic retinopathy or diabetic macular edema, developed in 37.5% of the sham group but in none of the OTX-TKI treated eyes.